Dr. Hidayat Hussain

Profil

Derzeitige StellungProfessor W-2 und Äquivalente
FachgebietNaturstoffchemie,Pharmazie
KeywordsTriterpene saponin, Diabetes, Omani Medicinal plants, Steroidal saponin, Natural Product

Aktuelle Kontaktadresse

LandOman
OrtNizwa
Universität/InstitutionThe University of Nizwa
Institut/AbteilungChair of Medicinal plants and marine natural products

Gastgeber*innen während der Förderung

Prof. Dr. Ludger WessjohannAbteilung Natur- und Wirkstoffchemie, Leibniz-Institut für Pflanzenbiochemie, Halle (IPB), Halle (Saale)
Beginn der ersten Förderung01.02.2018

Programm(e)

2017Humboldt-Forschungsstipendien-Programm für erfahrene Forschende

Publikationen (Auswahl)

2020Hussain, Hidayat and Ali, Iftikhar and Wang, Daijie and Mamadalieva, Nilufar Z and Hussain, Wahid and Csuk, Ren{\'e} and Loesche, Anne and Fischer, Lucie and Staerk, Dan and Anam, Syariful and others: 4-Benzyloxylonchocarpin and Muracatanes AC from Ranunculus muricatus L. and Their Biological Effects. In: Biomolecules, 10, 2020, 1562
2020Ghulam Abbas, Muhammad Ali, Ahmad Hamaed, Mohammed Al-Sibani, Hidayat Hussain, Ahmed Al-Harrasi : Azadirachta indica: the medicinal properties of the global problems-solving tree. In: Munir Ozturk, Dilfuza Egamberdieva, Milica Peši?, Biodiversity and Biomedicine. Elsevier, 2020. 1-18
2020Hidayat Hussain, Mamona Nazir, Muhammad Saleem, Ahmed Al-Harrasi, Elizbit, Ivan R. Green: Fruitful decade of Fungal Metabolites as Anti-diabetic agents from 2010-2019: Emphasis on ?-Glucosidase Inhibitors. In: Phytochemistry Reviews , 2020, 1-17
2020Mamona Nazir, Muhammad Saleem, Iftikhar Ali, Ghulam Abbas, Najeeb Ur Rehman, Ivan R. Green, Wahid Hussain, Saima Khan, Hidayat Hussain: Fungal metabolites as Anti-diabetic agents: Emphasis on PTP1B inhibitors. In: Phytochemistry Reviews, 2020, 1-12
2020Ghulam Abbas, Quazi M. I. Haq, Ahmad Hamaed, Mohammed Al-Sibani, Hidayat Hussain: Glucagon and Glucagon-like Peptide-1 Receptors: Promising Therapeutic Targets for an Effective Management of Diabetes Mellitus. In: Current Pharmaceutical Design, 2020, 1-7
2019Umair Shamraiz, Zeeshan Ahmad, Amin Badshah, Hidayat Hussain, Ghulam Abbas, Sajid Ullah, Bareera Raza: ?-Glucosidase Inhibition (antidiabetic) of Rubidium doped Indium Sulfide Nanomaterials. In: Materials Research Express , 2019, 1-7
2019Hidayat Hussain, Ghulam Abbas, Ivan R. Green, Iftikhar Ali: Dipeptidyl Peptidase IV Inhibitors as a Potental Target for Diabetes: Patent Review (2015-2018). In: Expert Opinion on Therapeutic Patents, 2019, 535-553
2019Hidayat Hussain, Ivan R. Green, Ghulam Abbas, Sergazy M. Adekenov, Wahid Hussain, Iftikhar Ali: Protein Tyrosine Phosphatase 1B (PTP1B) Inhibitors as Potental Anti-diabetes Agents: Patent Review (2015-2018). In: Expert Opinion on Therapeutic Patents, 2019, 689-702
2019Ghulam Abbas, Ahmed Al Harrasi, Hidayat Hussain, Ahmed Hamaed, Claudiu T.Supurana: The management of diabetes mellitus-imperative role of natural products against dipeptidyl peptidase-4, ?-glucosidase and sodium-dependent glucose co-transporter 2 (SGLT2). In: Bioorganic Chemistry, 2019, 305-315
2019Hidayat Hussain, Ivan R, Green, Muhammad Saleem, Muhammad Liaquat Raza, Mamona Nazir: Therapeutic Potential of Iridoid Derivatives: Patent Review . In: Inventions, 2019, 29-44
2018Hidayat Hussain, René Csuk, Ivan R. Green, Najeeb Ur Rehman, Ghulam Abbas, Wahid Hussain Journey Describing the Cytotoxic Potential of Withanolides: A Patent Review . In: Recent Patents on Anti-Cancer Drug Discovery, 2018, 411-421